HealthcareIT News – UPMC Enterprises, the innovation and commercialization arm of the healthcare giant, led Series B funding in precision medicine initiatives for Omicia, a clinical genome interpretation and reporting software company.
“As an investor, UPMC is excited to work with Omicia to begin to address today’s extraordinary opportunities in precision medicine,” Tal Heppenstall, president of UPMC Enterprises, said in a statement. “We envision a future in which we can routinely deliver actionable genomic insights about individual patients in real-time, within the workflow of our 3,500 physicians.”
A (Dog’s) Day in the Life: Work from Home Edition
My name is Denali. I’m one of the regular Doggie Day “coworkers” at UPMC Enterprises. However, it has been a couple months since my mom started working from home full-time.
Meet the Executive: David Gibson, Chief Financial Officer of UPMC Enterprises
David Gibson was named Chief Financial Officer of UPMC Enterprises in November 2019. As CFO, …